Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$152B
| $9.8M | 0.01% |
414,866
+1,994
| +0.5% | +$44.3K |
2021 Q2
20 quarters
|
|
702
10x Genomics
TXG
$9.13B
| $9.6M | 0.01% |
250,121
-361,493
| -59% | -$9.47M |
2025 Q1
5 quarters
|
|
703
Kailera Therapeutics
KLRA
$1.67B
| $9.6M | 0.01% |
+434,069
| New | +$9.5M |
2026 Q2
0 quarters
|
|
704
InterDigital
IDCC
$8.02B
| $9.6M | 0.01% |
33,754
-1,806
| -5% | -$537K |
2024 Q1
9 quarters
|
|
705
HP
HPQ
$26B
| $9.47M | 0.01% |
431,429
+104,659
| +32% | +$2.32M |
2013 Q2
52 quarters
|
|
706
BioMarin Pharmaceuticals
BMRN
$11.3B
| $9.36M | 0.01% |
163,619
+1,522
| +0.9% | +$83.4K |
2024 Q2
8 quarters
|
|
707
Costamare
CMRE
$1.71B
| $9.13M | 0.01% |
650,869
+328,708
| +102% | +$5.39M |
2022 Q3
15 quarters
|
|
708
Life Time Group Holdings
LTH
$10.1B
| $9.1M | 0.01% |
222,934
+1,728
| +0.8% | +$54.8K |
2024 Q3
7 quarters
|
|
709
Coeur Mining
CDE
$13.5B
| $9M | 0.01% |
551,674
-624,367
| -53% | -$11.4M |
2025 Q3
3 quarters
|
|
710
Myriad Genetics
MYGN
$607M
| $8.97M | 0.01% |
1,570,314
-405,852
| -21% | -$1.84M |
2020 Q1
25 quarters
|
|
711
Canadian Imperial Bank of Commerce
CM
$106B
| $8.94M | 0.01% |
77,758
-20,619
| -21% | -$2.26M |
2013 Q2
52 quarters
|
|
712
Stoneridge
SRI
$162M
| $8.89M | 0.01% |
1,214,355
+28,755
| +2% | +$197K |
2024 Q4
6 quarters
|
|
713
HawkEye 360 Inc
HAWK
$1.33B
| $8.86M | 0.01% |
+438,195
| New | +$12.1M |
2026 Q2
0 quarters
|
|
714
Novartis
NVS
$304B
| $8.83M | 0.01% |
56,351
-76
| -0.1% | -$11.4K |
2013 Q2
52 quarters
|
|
715
C.H. Robinson
CHRW
$14.4B
| $8.82M | 0.01% |
46,825
-7,639
| -14% | -$1.36M |
2021 Q2
20 quarters
|
|
716
TechnipFMC
FTI
$26.7B
| $8.78M | 0.01% |
132,435
-13,489
| -9% | -$955K |
2022 Q4
14 quarters
|
|
717
Globe Life
GL
$12.2B
| $8.75M | 0.01% |
48,977
+888
| +2% | +$139K |
2015 Q3
43 quarters
|
|
718
International Seaways
INSW
$5.73B
| $8.75M | 0.01% |
114,230
+113,148
| +10,457% | +$9.17M |
2022 Q3
15 quarters
|
|
719
indie Semiconductor
INDI
$382M
| $8.71M | 0.01% |
1,940,903
+5,276
| +0.3% | +$21K |
2026 Q1
1 quarter
|
|
720
Kohl's
KSS
$2.76B
| $8.71M | 0.01% |
491,790
+7,396
| +2% | +$110K |
2025 Q3
3 quarters
|
|
721
Bank of Hawaii
BOH
$2.74B
| $8.66M | 0.01% |
106,236
+9,202
| +9% | +$720K |
2025 Q2
4 quarters
|
|
722
Willis Towers Watson
WTW
$29.9B
| $8.65M | 0.01% |
33,109
-5,122
| -13% | -$1.37M |
2016 Q1
41 quarters
|
|
723
Carvana
CVNA
$75.3B
| $8.65M | 0.01% |
131,412
-1,802,728
| -93% | -$127M |
2023 Q4
10 quarters
|
|
724
ARKO Corp
ARKO
$425M
| $8.64M | 0.01% |
+1,076,420
| New | +$7.55M |
2026 Q2
0 quarters
|
|
725
BrightSpire Capital
BRSP
$426M
| $8.63M | 0.01% |
1,583,821
+45,195
| +3% | +$259K |
2023 Q2
12 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.